Question to the Department of Health and Social Care:

To ask Her Majesty's Government what assessment they have made of whether UK residents who have received the AstraZeneca COVID-19 vaccine produced in India will be prevented from using the digital COVID-19 passport to travel to Europe without tests and quarantine; and what steps they plan to take to help anyone so affected.

All University of Oxford/AstraZeneca vaccines administered in the United Kingdom are the same product and appear on the NHS COVID Pass as ‘Vaxzevria’. The European Medicines Agency has authorised Vaxzevria and it is recognised by the European Union for the purpose of travel.